Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The FOCUS trial (NCT03811561), which is being conducted to study the long-term effects of semaglutide in diabetic eye disease, is ongoing and is expected to end in 2027
April 29, 2026
Absorption and distribution characteristics were optimal for subcutaneous administration, with the drug reaching therapeutic concentrations within the expected timeframe and maintaining consistent exposure throughout the dosing interval
Look at the sheer number of people affected
US$ 25.94
US$ 20.88
US$ 24.28
US$ 25.50
